Clopidogrel thiolactone is an active metabolites containing thiols resulting from thionolactone transformation of clopidogrel . Clopidogrel thiolactone is a P2Y12 receptor inhibitor, is a potent antiplatelet agent In Vivo Clopidogrel thiolactone (8 μm/kg; i.v.; Sprague-Dawley male rats) has good biological availability and pharmacokinetic parameters . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Sprague-Dawley male rats Dosage: 8 μm/kg; orally clopidogrel (24 μm/kg) Administration: Intravenous injection; collected blood at 0 h (before dosing) and 0.083, 0.167, 0.5, 1, 2, 4, 6, 8, 24 h postdose. Result: 1.19 Parameter Clopidogrel C max (μg/L) 6.93 T max (h) 0.583 t 1/2 (h) 2.48 AUC 0-∞ (μg*h/L) 32.2 Form:Solid IC50& Target:P2Y12 Receptor